Overdiagnosis Crisis: Women Receive Unnecessary Antibiotics for UTIs

A woman comes to her doctor with burning during urination and a persistent urge to empty her bladder. The symptoms are real. The discomfort is real. Within minutes, she walks out with a prescription for antibiotics—often without a urine test to confirm that bacteria are actually present. This scene repeats thousands of times each week across the country, and it is reshaping the landscape of infectious disease in ways that extend far beyond any single patient's immediate relief.

The problem is straightforward in its mechanics but stubborn in its persistence. Urinary tract infections produce recognizable symptoms, and those symptoms alone have become sufficient justification for treatment in many clinical settings. A woman reports dysuria and frequency, and the prescription pad comes out. The logic seems sound: why wait for test results when the patient is suffering? Yet this reasoning has created a parallel epidemic, one measured not in the number of people who get sick but in the number of people treated for infections that may never have existed.

When a urine culture is actually performed—the gold standard for confirming a UTI—it frequently comes back negative or shows no significant bacterial growth. This means the woman received antibiotics for a condition she did not have. The immediate consequence is personal: she may experience side effects ranging from mild gastrointestinal upset to severe allergic reactions or dangerous complications like Clostridioides difficile infection, which can cause severe diarrhea and colitis. But the consequence extends beyond her body into the broader microbial ecosystem.

Every unnecessary antibiotic prescription is a selective pressure event. Bacteria that survive the drug become more resistant to it. Over time, as this pattern repeats across millions of prescriptions, the bacteria circulating in the population become harder to kill. Drugs that once reliably cured infections now fail. Infections that were once minor threats become serious ones. A simple UTI can progress to sepsis. Routine surgical procedures become riskier because the prophylactic antibiotics no longer work as expected. This is not hypothetical—antibiotic resistance is already killing tens of thousands of Americans annually and complicating treatment of infections worldwide.

The diagnostic overreach stems partly from clinical culture and partly from genuine uncertainty. Symptoms of a UTI can overlap with other conditions—urethritis, vaginitis, interstitial cystitis—that do not respond to antibiotics and do not require them. A urine dipstick test, which many clinicians rely on, can show signs of infection without actual bacterial presence. The test is fast and inexpensive, which makes it appealing in busy practices, but it is also prone to false positives. A proper urine culture takes days to result, and in the meantime, the patient is uncomfortable. The pressure to act now rather than wait for confirmation is real.

Yet the evidence increasingly suggests that this pressure has created a system optimized for overtreating rather than for treating appropriately. Studies show that many women prescribed antibiotics for presumed UTIs would have recovered without treatment, their symptoms resolving on their own as the body's natural defenses cleared the irritation. Others had no infection at all. The antibiotics provided no benefit but carried all the risk.

Clinical reform is possible. Better diagnostic protocols—using urine cultures more consistently, setting clearer thresholds for what constitutes a confirmed infection, educating physicians about the difference between bacteriuria (bacteria in the urine) and actual infection—could substantially reduce inappropriate prescribing. Some health systems have already implemented such changes and seen dramatic reductions in antibiotic use for UTIs without worsening patient outcomes. The challenge now is scaling these practices, changing the habits of clinicians trained under older paradigms, and resisting the institutional inertia that makes the quick prescription feel safer than the careful diagnosis. The stakes are not just individual comfort but the future utility of the drugs we depend on.